IOL CHEMICALS & PHARM. | BDH INDUS. | IOL CHEMICALS & PHARM./ BDH INDUS. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 18.4 | 67.2% | View Chart |
P/BV | x | 1.4 | 3.0 | 47.4% | View Chart |
Dividend Yield | % | 1.1 | 1.4 | 78.0% |
IOL CHEMICALS & PHARM. BDH INDUS. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
BDH INDUS. Mar-23 |
IOL CHEMICALS & PHARM./ BDH INDUS. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 211 | 254.1% | |
Low | Rs | 272 | 93 | 294.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 129.3 | 292.1% | |
Earnings per share (Unadj.) | Rs | 23.7 | 14.2 | 166.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 15.2 | 207.2% | |
Dividends per share (Unadj.) | Rs | 4.00 | 4.00 | 100.0% | |
Avg Dividend yield | % | 1.0 | 2.6 | 37.6% | |
Book value per share (Unadj.) | Rs | 256.8 | 95.0 | 270.4% | |
Shares outstanding (eoy) | m | 58.71 | 5.76 | 1,019.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.2 | 91.2% | |
Avg P/E ratio | x | 17.1 | 10.7 | 160.1% | |
P/CF ratio (eoy) | x | 12.8 | 10.0 | 128.6% | |
Price / Book Value ratio | x | 1.6 | 1.6 | 98.5% | |
Dividend payout | % | 16.9 | 28.1 | 60.1% | |
Avg Mkt Cap | Rs m | 23,743 | 874 | 2,715.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 70 | 2,417.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 745 | 2,977.7% | |
Other income | Rs m | 256 | 8 | 3,045.2% | |
Total revenues | Rs m | 22,427 | 753 | 2,978.5% | |
Gross profit | Rs m | 2,257 | 110 | 2,060.3% | |
Depreciation | Rs m | 462 | 6 | 8,112.5% | |
Interest | Rs m | 165 | 2 | 10,424.1% | |
Profit before tax | Rs m | 1,887 | 111 | 1,704.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 29 | 1,729.3% | |
Profit after tax | Rs m | 1,391 | 82 | 1,695.8% | |
Gross profit margin | % | 10.2 | 14.7 | 69.2% | |
Effective tax rate | % | 26.2 | 25.9 | 101.5% | |
Net profit margin | % | 6.3 | 11.0 | 57.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 605 | 1,598.2% | |
Current liabilities | Rs m | 5,025 | 246 | 2,041.9% | |
Net working cap to sales | % | 20.9 | 48.2 | 43.5% | |
Current ratio | x | 1.9 | 2.5 | 78.3% | |
Inventory Days | Days | 43 | 3 | 1,722.1% | |
Debtors Days | Days | 8 | 816 | 1.0% | |
Net fixed assets | Rs m | 11,017 | 195 | 5,637.2% | |
Share capital | Rs m | 587 | 58 | 1,019.8% | |
"Free" reserves | Rs m | 14,490 | 489 | 2,961.0% | |
Net worth | Rs m | 15,077 | 547 | 2,756.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 800 | 2,584.6% | |
Interest coverage | x | 12.5 | 71.1 | 17.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.9 | 115.2% | |
Return on assets | % | 7.5 | 10.4 | 72.0% | |
Return on equity | % | 9.2 | 15.0 | 61.5% | |
Return on capital | % | 13.6 | 20.5 | 66.3% | |
Exports to sales | % | 26.7 | 51.7 | 51.8% | |
Imports to sales | % | 0 | 29.7 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 385 | 1,541.7% | |
Imports (cif) | Rs m | NA | 221 | 0.0% | |
Fx inflow | Rs m | 5,930 | 385 | 1,541.7% | |
Fx outflow | Rs m | 6,052 | 221 | 2,734.5% | |
Net fx | Rs m | -122 | 163 | -74.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 63 | 1,942.6% | |
From Investments | Rs m | -1,200 | 5 | -24,640.7% | |
From Financial Activity | Rs m | -41 | 4 | -1,126.0% | |
Net Cashflow | Rs m | -18 | 71 | -25.7% |
Indian Promoters | % | 48.2 | 41.6 | 115.8% | |
Foreign collaborators | % | 0.0 | 8.1 | - | |
Indian inst/Mut Fund | % | 2.5 | 0.0 | - | |
FIIs | % | 2.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 50.3 | 102.9% | |
Shareholders | 134,235 | 5,111 | 2,626.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | BDH INDUS. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | -3.43% | 1.18% |
1-Month | -9.26% | -5.08% | -0.75% |
1-Year | 29.97% | 157.09% | 61.82% |
3-Year CAGR | -13.41% | 45.27% | 18.16% |
5-Year CAGR | 13.41% | 29.74% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the BDH INDUS. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of BDH INDUS. the stake stands at 49.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of BDH INDUS..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
BDH INDUS. paid Rs 4.0, and its dividend payout ratio stood at 28.1%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of BDH INDUS..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.